Jonathan Slonin, Chief Clinical Officer at Pacira BioSciences, Inc. (PCRX), sold 308 shares at $55.70 ($17K) on 2022-08-03, disclosed to the SEC on 2022-08-05.
Open-market sale of $17k PCRX by Chief Clinical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PCRX | SELL | 2025-11-19 | $191K | — | Filing → |
| PCRX | SELL | 2025-01-06 | $16K | — | Filing → |
| PCRX | SELL | 2024-08-02 | $19K | — | Filing → |